Literature DB >> 22886258

Expression of VHHs in Saccharomyces cerevisiae.

Andrea Gorlani1, Hans de Haard, Theo Verrips.   

Abstract

The production of VHHs in microorganisms is relatively straightforward, however the amount of VHH produced per volume unit can vary substantially from hardly detectable to hundreds of milligrams per liter. Expression in Escherichia coli is more commonly used at initial research phase, since production of VHHs for large-scale application in E. coli is for a number of reasons not preferred. Otherwise VHH production in GRAS organisms such as Saccharomyces cerevisiae fits very well with industrial fermentation processes, and in fact the only commercially available VHHs are produced in S. cerevisiae. Immediately after the discovery of heavy chain only antibodies, which are per definition devoid of light chains, it was investigated whether many problems encountered with the production of conventional antibodies in lower eukaryotes were absent during the production of VHHs. Here we provide a protocol for the expression of VHH genes in S. cerevisiae in a fed-batch fermentation process. This protocol is also suitable for the production of multivalent VHHs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886258     DOI: 10.1007/978-1-61779-968-6_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.

Authors:  Angela I Schriek; Marlies M van Haaren; Meliawati Poniman; Gillian Dekkers; Arthur E H Bentlage; Marloes Grobben; Gestur Vidarsson; Rogier W Sanders; Theo Verrips; Teunis B H Geijtenbeek; Raimond Heukers; Neeltje A Kootstra; Steven W de Taeye; Marit J van Gils
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

2.  Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins.

Authors:  Thomas De Meyer; Dominique Eeckhout; Riet De Rycke; Sylvie De Buck; Serge Muyldermans; Ann Depicker
Journal:  Plant Mol Biol       Date:  2013-08-21       Impact factor: 4.076

3.  A probiotic yeast-based immunotherapy against Clostridioides difficile infection.

Authors:  Kevin Chen; Yixuan Zhu; Yongrong Zhang; Therwa Hamza; Hua Yu; Ashley Saint Fleur; James Galen; Zhiyong Yang; Hanping Feng
Journal:  Sci Transl Med       Date:  2020-10-28       Impact factor: 17.956

4.  Antiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2.

Authors:  Eileen M Geoghegan; Hong Zhang; Prashant J Desai; Arya Biragyn; Richard B Markham
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.938

5.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

6.  Fungal Glucosylceramide-Specific Camelid Single Domain Antibodies Are Characterized by Broad Spectrum Antifungal Activity.

Authors:  Barbara De Coninck; Peter Verheesen; Christine M Vos; Inge Van Daele; Miguel F De Bolle; Joao V Vieira; Marnix Peferoen; Bruno P A Cammue; Karin Thevissen
Journal:  Front Microbiol       Date:  2017-06-14       Impact factor: 5.640

Review 7.  Theranostics in immuno-oncology using nanobody derivatives.

Authors:  Quentin Lecocq; Yannick De Vlaeminck; Heleen Hanssens; Matthias D'Huyvetter; Geert Raes; Cleo Goyvaerts; Marleen Keyaerts; Nick Devoogdt; Karine Breckpot
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

8.  Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region.

Authors:  Rahma Ben Abderrazek; Ayoub Ksouri; Faten Idoudi; Sayda Dhaouadi; Emna Hamdi; Cécile Vincke; Azer Farah; Zakaria Benlasfar; Hafedh Majdoub; Mohamed El Ayeb; Serge Muyldermans; Balkiss Bouhaouala-Zahar
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

9.  High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli.

Authors:  Kristof Zarschler; Stefanie Witecy; Franz Kapplusch; Christian Foerster; Holger Stephan
Journal:  Microb Cell Fact       Date:  2013-10-27       Impact factor: 5.328

Review 10.  Microbials for the production of monoclonal antibodies and antibody fragments.

Authors:  Oliver Spadiut; Simona Capone; Florian Krainer; Anton Glieder; Christoph Herwig
Journal:  Trends Biotechnol       Date:  2013-10-31       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.